Altimmune (NASDAQ:ALT) Rating Increased to Strong-Buy at Barclays
Barclays raised shares of Altimmune to a "strong-buy" rating in a research report on Tuesday...
MarketBeat·2d ago
Altimmune (ALT) Shares Slide On $75 Million Stock Offering
Altimmune shares are tumbling on Wednesday following the company's announcement of a $75 million registered direct offering of common stock.read more...
Benzinga·2d ago
Altimmune (NASDAQ:ALT) Shares Gap Down - Here's Why
Altimmune (NASDAQ:ALT) Shares Gap Down - Time to Sell...
MarketBeat·3d ago
Nasdaq, S&P 500 Futures Edge Higher Ahead Of Fed Decision, Mag 7 Earnings Kick Off: Why NVDA, ASML, ALT, AI, UUU Are On Traders' Radar Today
Retail sentiment on major ETFs such as SPY and QQQ turned ‘extremely bearish’ on Stocktwits.
Stocktwits·3d ago
ALT Stock Surges Toward Sixth Straight Day Of Gains: Retail Bets A Buyout Is On The Horizon
Altimmune plans to raise $75 million via a direct offering to bankroll its Phase 3 MASH trial, easing near-term funding risk.
Stocktwits·3d ago
Altimmune (NASDAQ:ALT) Trading 16.1% Higher - Should You Buy?
Altimmune (NASDAQ:ALT) Trading Up 16.1% - Should You Buy...
MarketBeat·8d ago
Stock Traders Purchase High Volume of Call Options on Altimmune (NASDAQ:ALT)
Altimmune, Inc. (NASDAQ:ALT - Get Free Report) was the target of unusually large options trading activity on Friday. Stock investors bought 14,727 call options on the stock. This represents an...
MarketBeat·8d ago
Nasdaq, S&P 500 Futures Subdued Ahead Of PMI Data: Why INTC, TSLA, NFLX, VST, MOVE Are On Traders' Radar Today
Retail sentiment on Stocktwits for SPY and QQQ remained ‘bearish’.